Open AccessThis article is
- freely available
Holothurian Fucosylated Chondroitin Sulfate
Program of Glycobiology, Institute of Medical Biochemistry Leopoldo de Meis, and University Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941-913, Brazil
Received: 5 November 2013; in revised form: 23 December 2013 / Accepted: 30 December 2013 / Published: 9 January 2014
Abstract: Fucosylated chondroitin sulfate (FucCS) is a structurally distinct glycosaminoglycan found in sea cucumber species. It has the same backbone composition of alternating 4-linked glucuronic acid and 3-linked N-acetyl galactosamine residues within disaccharide repeating units as regularly found in mammalian chondroitin sulfates. However, FucCS has also sulfated fucosyl branching units 3-O-linked to the acid residues. The sulfation patterns of these branches vary accordingly with holothurian species and account for different biological actions and responses. FucCSs may exhibit anticoagulant, antithrombotic, anti-inflammatory, anticancer, antiviral, and pro-angiogenic activities, besides its beneficial effects in hemodialysis, cellular growth modulation, fibrosis and hyperglycemia. Through an historical overview, this document covers most of the science regarding the holothurian FucCS. Both structural and medical properties of this unique GAG, investigated during the last 25 years, are systematically discussed herein.
Keywords: carbohydrate-based drug development; chondroitin sulfate; fucose; sulfated glycosaminoglycan; echinoderm; therapeutic actions
Citations to this Article
Cite This Article
MDPI and ACS Style
Pomin, V.H. Holothurian Fucosylated Chondroitin Sulfate. Mar. Drugs 2014, 12, 232-254.
Pomin VH. Holothurian Fucosylated Chondroitin Sulfate. Marine Drugs. 2014; 12(1):232-254.
Pomin, Vitor H. 2014. "Holothurian Fucosylated Chondroitin Sulfate." Mar. Drugs 12, no. 1: 232-254.